Metraipolis › archive › dc_a718a0dfab3d

Rethinking secondary immunodeficiency: a cross-domain pathway framework for risk stratification — Europe PMC PMID:42718590

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42718590
DOI
10.3389/fimmu.2026.1866662
License (as archived)
solo-consultazione
Archived
2026-10-08T14:46:04.720Z
SHA-256 of the archived text
0656894786ebdcc58bd2e6864972d7833d7dd9462405dc99cf9915df4096e5d6
Stable URL of this page
https://metraipolis.com/documento/dc_a718a0dfab3d

How to cite

Rethinking secondary immunodeficiency: a cross-domain pathway framework for risk stratification — Europe PMC PMID:42718590 — Europe PMC (en), https://europepmc.org/article/MED/42718590 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a718a0dfab3d (Metraipolis archive dc_a718a0dfab3d, sha256 0656894786ebdcc58bd2e6864972d7833d7dd9462405dc99cf9915df4096e5d6)
BibTeX
@misc{dca718a0dfab3d,
  title = {Rethinking secondary immunodeficiency: a cross-domain pathway framework for risk stratification — Europe PMC PMID:42718590},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42718590},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a718a0dfab3d; sha256 0656894786ebdcc58bd2e6864972d7833d7dd9462405dc99cf9915df4096e5d6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42718590. Agents can read the archived copy with the MCP tool read_document.